Levofloxacin Fresenius Kabi

Levofloxacin, the active ingredient in Levofloxacin Fresenius Kabi, is a fluoroquinolone antibiotic presented as an injectable solution for intravenous use. It treats a range of serious bacterial infections in adults, including community‑acquired and hospital‑acquired pneumonia, complicated urinary tract infections, skin and soft‑tissue infections, and septicemia.

GNH USA supplies Levofloxacin Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used for bacterial infections affecting the respiratory, urinary, skin and systemic systems.

Community‑acquired pneumonia: achieves bacterial eradication and clinical cure in adult patients. Hospital‑acquired pneumonia: provides effective coverage against common nosocomial pathogens. Complicated urinary tract infections: clears infection and resolves symptoms. Skin and soft‑tissue infections: reduces bacterial load and promotes healing. Septicemia: contributes to rapid bacterial clearance and improves survival outcomes.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: occasional vertiginous sensation. - Rash: mild skin erythema or pruritus. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur without warning. - QT interval prolongation: risk of ventricular arrhythmias. - Clostridioides difficile infection: severe colitis following dysbiosis. - Severe allergic reactions: anaphylaxis, Stevens‑Johnson syndrome. - Seizures: particularly in patients with CNS disorders. - Hepatic failure: rare but potentially life‑threatening liver injury.

Levofloxacin should be used with caution in specific clinical situations.

Renal function: adjust dosing in patients with impaired renal clearance. CNS effects: monitor for seizures, especially in patients with a history of epilepsy. Tendon health: avoid in individuals with prior tendon disorders or those on corticosteroids. QT interval: use cautiously in patients with known cardiac arrhythmias or electrolyte abnormalities. Pregnancy and lactation: risk unknown; prescribe only when benefits outweigh potential risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce levofloxacin absorption. - Warfarin: may increase INR and bleeding risk. - Cyclosporine: elevated cyclosporine concentrations. - Theophylline: increased theophylline toxicity. - NSAIDs: heightened risk of CNS stimulation and seizures.

Moderate Interactions (Monitor Closely): - Oral contraceptives: reduced hormonal efficacy, consider backup method. - Diabetic agents: potential for enhanced hypoglycaemia. - Corticosteroids: additive risk of tendon rupture. - Diuretics: possible electrolyte disturbances. - Rifampin: decreased levofloxacin plasma levels, may reduce effectiveness.